Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

971
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
971
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanism.

Brain communications·2026
Same author

Classical Proprioceptors and Palisade Endings Have Distinct Molecular Profiles in Pig Eye Muscles.

Investigative ophthalmology & visual science·2026
Same author

The Calcium-Binding Protein S100A10 (p11) Is Required for Normal Motor Performance by Regulating Vesicle Dynamics at Excitatory Synapses.

Acta physiologica (Oxford, England)·2026
Same author

GABA and Glycine Synaptic Release on Axotomized Motoneuron Cell Bodies Promotes Motor Axon Regeneration.

The European journal of neuroscience·2025
Same author

GABA and glycine synaptic release on axotomized motoneuron cell bodies promotes motor axon regeneration.

bioRxiv : the preprint server for biology·2024
Same author

VEGF, but Not BDNF, Prevents the Downregulation of KCC2 Induced by Axotomy in Extraocular Motoneurons.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Aug 28, 2025

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.8K

VEGF and Neuronal Survival.

Paula M Calvo1, Rosendo G Hernández1, Angel M Pastor1

  • 1Departamento de Fisiología, Facultad de Biología, Universidad de Sevilla, Sevilla, Spain.

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|September 19, 2022
PubMed
Summary
This summary is machine-generated.

Vascular endothelial growth factor (VEGF) protects neurons. VEGF deficiency is linked to motoneuron degeneration and amyotrophic lateral sclerosis (ALS), suggesting VEGF as a potential therapeutic target for these disorders.

Keywords:
ALSaxotomyextraocular motoneuronsneuroprotectionneurotrophic factors

More Related Videos

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects
08:48

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects

Published on: February 17, 2016

9.4K
Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia SCG
11:49

Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia SCG

Published on: January 30, 2009

23.1K

Related Experiment Videos

Last Updated: Aug 28, 2025

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.8K
Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects
08:48

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects

Published on: February 17, 2016

9.4K
Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia SCG
11:49

Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia SCG

Published on: January 30, 2009

23.1K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Vascular endothelial growth factor (VEGF) is primarily known for its role in angiogenesis.
  • Emerging evidence indicates VEGF also possesses significant neuroprotective properties for neurons under stress or injury.

Purpose of the Study:

  • To review the evidence linking VEGF deficiency to neuronal degeneration.
  • To explore the therapeutic potential of VEGF in motoneuron disorders.

Main Methods:

  • Review of studies on VEGF deficiency in mouse models.
  • Analysis of studies administering VEGF to animal models of neurodegeneration.
  • Examination of associations between plasma VEGF levels and human ALS.

Main Results:

  • Mice with reduced VEGF exhibit motoneuron degeneration and muscle weakness, mimicking amyotrophic lateral sclerosis (ALS).
  • VEGF administration improves motor function and reduces degeneration in animal models of motoneuron disease.
  • Lower plasma VEGF levels correlate with human ALS cases.

Conclusions:

  • VEGF is a crucial neurotrophic factor for motoneurons.
  • VEGF demonstrates significant therapeutic potential for treating motoneuron degeneration and related disorders like ALS.